MMP9 and neoplasm: In addition to the increased expression of the prospective prostate CS/IC marker CD133 [47], tumor hybrids also exhibited a decreased E-cadherin expression, but increased protein levels of AKT, MMP9, and vimentin, suggesting that hybrids may have undergone EMT [88].